Partner Kathryn Kayali has been recognized as a Law360 Rising Star for Life Sciences. According to the publication, after receiving more than 1,100 nominations, Law360 selected 4-6 honorees from each practice area, all under the age of 40, “whose legal accomplishments belie their age.”
Kathryn’s practice is focused on patent litigation, particularly in the pharmaceutical sector, and her experience includes litigation concerning both small-molecule and biologic drugs. She has experience handling pharmaceutical patent cases at every stage of litigation, from complaint through trial.
To view the complete list of Law360’s 2026 Rising Stars, click here.